1AD
Click for more information
3.85% 2.5¢ adalta limited

Ann: Positive AD-214 Phase I extension study results, page-189

  1. asx11
    3,369 Posts.
    lightbulb Created with Sketch. 353
    clock Created with Sketch.
    27/03/24
    10:39
    Post #: 73078395
    They wouldn't get the company for that because we wouldn't allow it. The company also has 2 paths to funding, they may not even end up partnering with pharma.
    Last edited by asx11: 27/03/24
    1AD Price at posting: 2.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢ 		Change
-0.001(3.85%) 		Mkt cap ! $14.89M
Open High Low Value Volume
2.6¢ 2.6¢ 2.5¢ $8.181K 325.6K

Buyers (Bids)

No. Vol. Price($)
2 1366992 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 36539 1
View Market Depth
Last trade - 12.05pm 27/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.